The top 5 players in the Lisinopril space

Innovation activity in the Lisinopril market has been, as a whole, growing over the last 5 years, with a 25.87% average growth rate. The highest annual increase came in 2018 when MSD filed 6 new patents within the space.

The 369 technologies are being applied within 10 different categories, the fastest growing of which is Biochemistry with a 53.33% increase in new patents filed over the past 5 years. The category “Medical” is seeing a lot of filings by new entrants, so it might be an emerging space worth looking into.

For deeper insights on the pharmaceutical industry or another area of focus, visit ipcypris.com and get started using the innovation dashboard and custom reports.